Double transplant attack shows promise against bone marrow cancer
NCT ID NCT01241708
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 27 times
Summary
This study tested a two-step treatment for multiple myeloma, a type of blood cancer. 148 patients received a first round of high-dose chemotherapy (melphalan) followed by a stem cell transplant, then a second round with melphalan plus another drug (bortezomib) and another transplant. The goal was to see if this approach could keep the cancer from coming back longer. Participants were between 18 and 75 years old and had to have enough stem cells stored for both transplants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
John Theurer Cancer Center @ Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
Conditions
Explore the condition pages connected to this study.